West Tower Group LLC Makes New Investment in Cabot Corporation $CBT

West Tower Group LLC bought a new position in shares of Cabot Corporation (NYSE:CBT) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 11,235 shares of the specialty chemicals company’s stock, valued at approximately $745,000. Cabot makes up about 1.7% of West Tower Group LLC’s investment portfolio, making the stock its 15th largest position.

Several other institutional investors also recently made changes to their positions in CBT. AQR Capital Management LLC boosted its position in shares of Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares in the last quarter. UBS Group AG boosted its position in shares of Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Cabot by 8.4% during the 3rd quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after purchasing an additional 140,665 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after purchasing an additional 108,645 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its position in shares of Cabot by 259.2% during the 3rd quarter. Victory Capital Management Inc. now owns 142,404 shares of the specialty chemicals company’s stock worth $10,830,000 after purchasing an additional 102,764 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Jefferies Financial Group restated a “buy” rating and set a $85.00 target price on shares of Cabot in a research report on Wednesday, February 4th. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. Mizuho boosted their price objective on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, UBS Group boosted their price objective on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $76.25.

Cabot Price Performance

NYSE:CBT opened at $84.53 on Wednesday. The firm has a market cap of $4.36 billion, a price-to-earnings ratio of 15.98, a price-to-earnings-growth ratio of 11.18 and a beta of 0.78. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The company’s 50-day moving average is $74.48 and its two-hundred day moving average is $70.73. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $86.43.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The company had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Research analysts expect that Cabot Corporation will post 6.25 EPS for the current year.

Cabot Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be issued a $0.4725 dividend. This is a positive change from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. Cabot’s payout ratio is currently 34.03%.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.